Gus Attridge — Aspen Pharmacare — South African tycoon — Johannesburg Stock Exchange — South Africa — Hot News
Aspen’s market slump wipes $52 million from South African tycoon Gus Attridge’s stake
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
Related
South African pharma tycoon Gus Attridge loses $7 million from Aspen stake
Shares of Aspen Pharmacare plunged 5.44 percent in a week, wiping millions off co-founder Gus Attridge’s stake.
Gus Attridge gains over $18 million as Aspen shares rebound
This follows a strong recovery in Aspen's share price on the Johannesburg Stock Exchange (JSE).
South African tycoon Gus Attridge loses $15.73 Million as Aspen stake sinks
Attridge, co-founder and group chief advisor of Aspen Pharmacare, holds a 4.3-percent stake in the company.
Gus Attridge’s stake in Africa’s largest pharma company drops by $12 million
His 19,188,850 shares are now valued at R3.24 billion ($175.82 million), reflecting the latest decline in Aspen’s stock price.
Latest
Mauritian businessman Arnaud Lagesse’s IBL Group posts $87 million profit
The results reflect the continued strength of its international operations, which helped cushion the impact of rising costs in its home market.
Moroccan businesswoman Lamia Tazi's stake in Sothema nears $90 million
This boost comes on the heels of a strong rally in Sothema’s share price on the Casablanca Bourse.
Shameel Joosub-led Vodacom bets big on contracts beyond mobile
The company’s results for the year ending March 31, 2025, underscore a business in transformation, yet also raise questions about financial transparency and consumer risk.
Patrice Motsepe's Tyme Bank, Sanlam to launch retail credit venture
TymeBank and Sanlam are launching a 50-50 joint venture to expand digital credit access to underserved South Africans through unsecured loans and insurance.